![]() |
Volumn 12, Issue 2, 2015, Pages 3101-3106
|
Effect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
5(S),6(R)-7-TRIHYDROXYHEPTANOIC ACID, METHYL ESTER;
CASPASE 3;
DEFENSIN;
HEPTANOIC ACID DERIVATIVE;
INTERLEUKIN 6;
NONSTEROID ANTIINFLAMMATORY AGENT;
TLR2 PROTEIN, RAT;
TLR4 PROTEIN, RAT;
TOLL LIKE RECEPTOR 2;
TOLL LIKE RECEPTOR 4;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR;
AGONISTS;
ANIMAL;
APOPTOSIS;
DISEASE MODEL;
DRUG EFFECTS;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
IMMUNOLOGY;
INTESTINE MUCOSA;
INTRAPERITONEAL DRUG ADMINISTRATION;
MALE;
MUCOSAL IMMUNITY;
PATHOLOGY;
RAT;
SEPSIS;
SIGNAL TRANSDUCTION;
SPRAGUE DAWLEY RAT;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
APOPTOSIS;
CASPASE 3;
DEFENSINS;
DISEASE MODELS, ANIMAL;
GENE EXPRESSION REGULATION;
HEPTANOIC ACIDS;
HUMANS;
IMMUNITY, MUCOSAL;
INJECTIONS, INTRAPERITONEAL;
INTERLEUKIN-6;
INTESTINAL MUCOSA;
MALE;
RATS;
RATS, SPRAGUE-DAWLEY;
SEPSIS;
SIGNAL TRANSDUCTION;
TOLL-LIKE RECEPTOR 2;
TOLL-LIKE RECEPTOR 4;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84991231363
PISSN: None
EISSN: 17913004
Source Type: Journal
DOI: 10.3892/mmr.2015.3746 Document Type: Article |
Times cited : (15)
|
References (0)
|